Pasqualetti P, Casale R
Department of Internal Medicine and Public Health, School of Medicine and Surgery, University of L'Aquila, Italy.
Riv Eur Sci Med Farmacol. 1995 Jul-Aug;17(4):125-9.
Since acquired deficiencies of fibrinogen and antithrombin III are reported in liver cirrhosis and it is known that their plasma levels fluctuate during the day, the circadian rhythms of plasma fibrinogen and plasma antithrombin III were investigated in patients with compensated and decompensated cirrhosis, compared to healthy controls.
Three groups of subject were considered: (A) 10 healthy controls; (B) 10 patients with compensated liver cirrhosis; (C) 10 patients with decompensated liver cirrhosis. The fibrinogen and antithrombin III levels were determined in blood samples drawn in each studied subject during the span of a whole day and every three hours starting from midnight. The time-related data were analyzed by means of the "mean-group cosinor" method.
Significant (p < 0.05) circadian rhythms were detected for the two variables in groups A and B, with peaks in the afternoon hours. No significant (p > 0.05) rhythms were found for group C. A significant (p < 0.05) difference was found between the three groups regarding the circadian rhythm of fibrinogen, and between controls and patients with compensated cirrhosis and between compensated and decompensated patients regarding the circadian rhythm of antithrombin III.
These data suggest that in healthy subjects the plasma levels of fibrinogen and antithrombin III present daily variations with own circadian rhythms, and that liver cirrhosis is associated with chronobiological circadian changes in the coagulation system, related to the stage of the disease. This progressive derangement could be considered as an index of evolution in the natural history of cirrhosis of the liver.
由于在肝硬化患者中报告了纤维蛋白原和抗凝血酶III的后天性缺乏,并且已知它们的血浆水平在一天中会波动,因此对代偿期和失代偿期肝硬化患者的血浆纤维蛋白原和血浆抗凝血酶III的昼夜节律进行了研究,并与健康对照进行了比较。
考虑了三组受试者:(A)10名健康对照;(B)10名代偿期肝硬化患者;(C)10名失代偿期肝硬化患者。在从午夜开始的一整天中,每隔三小时采集每个研究对象的血样,测定纤维蛋白原和抗凝血酶III水平。通过“平均组余弦分析”方法分析与时间相关的数据。
在A组和B组中,这两个变量检测到显著(p < 0.05)的昼夜节律,在下午时段达到峰值。C组未发现显著(p > 0.05)的节律。在纤维蛋白原的昼夜节律方面,三组之间存在显著(p < 0.05)差异;在抗凝血酶III的昼夜节律方面,对照组与代偿期肝硬化患者之间以及代偿期和失代偿期患者之间存在显著差异。
这些数据表明,在健康受试者中,纤维蛋白原和抗凝血酶III的血浆水平呈现出具有自身昼夜节律的每日变化,并且肝硬化与凝血系统的时间生物学昼夜变化有关,这与疾病阶段相关。这种逐渐的紊乱可被视为肝硬化自然史演变的一个指标。